Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
---|---|---|---|---|---|---|
Radiopharm Theranostics LtdRADX | 1 | Strong Buy | $12.00 | +195.57% | Initiates Coverage On | 8 days ago |
Chemomab Therapeutics LtdCMMB | 2 | Strong Buy | $7.00 | +469.11% | Maintains | 3 months ago |
Mainz Biomed NvMYNZ | 1 | Strong Buy | $14.00 | +449.02% | Initiates Coverage On | 3 months ago |
Lineage Cell Therapeutics IncLCTX | 1 | Strong Buy | $3.00 | +538.30% | Maintains | 4 months ago |
Citius Oncology IncCTOR | 1 | Strong Buy | $3.00 | +255.03% | Initiates Coverage On | 5 months ago |
Ocugen IncOCGN | 1 | Strong Buy | $4.00 | +480.55% | Initiates Coverage On | 7 months ago |
Fibrobiologics IncFBLG | 1 | Strong Buy | $12.00 | +1,318.44% | Initiates Coverage On | 7 months ago |
Longeveron IncLGVN | 2 | Strong Buy | $6.00 | +302.68% | Maintains | 8 months ago |
Lexaria Bioscience CorpLEXX | 2 | Strong Buy | $12.00 | N/A | Maintains | a year ago |
Dmk Pharmaceuticals CorpDMKPQ | 1 | Strong Buy | $1.50 | N/A | Initiates Coverage On | a year ago |
Acrivon Therapeutics IncACRV | 1 | Strong Buy | $24.00 | N/A | Initiates Coverage On | 2 years ago |
Anebulo Pharmaceuticals IncANEB | 1 | Strong Buy | $6.00 | N/A | Initiates Coverage On | 2 years ago |
Kiora Pharmaceuticals IncKPRX | 3 | Strong Buy | $18.00 | N/A | Maintains | 2 years ago |
Alzamend Neuro IncALZN | 1 | Strong Buy | $225.00 | N/A | Initiates Coverage On | 2 years ago |
Mediwound LtdMDWD | 1 | Strong Buy | $25.00 | N/A | Initiates Coverage On | 2 years ago |
Biorestorative Therapies IncBRTX | 1 | Strong Buy | $6.00 | N/A | Initiates Coverage On | 3 years ago |
Hcw Biologics IncHCWB | 1 | Strong Buy | $160.00 | N/A | Initiates Coverage On | 3 years ago |
Atlantic International CorpATLN | 1 | Strong Buy | $120.00 | N/A | Initiates Coverage On | 3 years ago |
Atai Life Sciences NvATAI | 1 | Strong Buy | $25.00 | N/A | Initiates Coverage On | 3 years ago |
Citius Pharmaceuticals IncCTXR | 1 | Strong Buy | $100.00 | N/A | Initiates Coverage On | 3 years ago |